newsfilter
← Latest News
GlobeNewswire·

Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®

EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel's proprietary microencapsulation technology for the treatment of inflammatory lesions of rosacea and is patent protected until 2040 Galderma set to commercialize EPSOLAY in the U.S. under exc